Protocol for a scoping review: Patients’ and clinicians’ preferences on the usage of blood biomarkers for Alzheimer’s disease.

Open Science Framework 2026 Open access

Read full text
Authors: Liuhao Wu
DOI: 10.17605/osf.io/pab5m
Cited by: 0

Abstract

Given the increasing interest in blood-based biomarkers for Alzheimer’s disease, this scoping review seeks to synthesise the available evidence on the patients’ and clinicians’ attitude towards introducing blood-based biomarkers in primary and secondary care settings.

Fields of Study & Subjects

Dementia and Cognitive Impairment Research Alzheimer's disease research and treatments Patient-Provider Communication in Healthcare

Publication details

Journal / source
Open Science Framework
Publication date
1 January 2026
Language
EN